BOSTON (AP) — A Massachusetts drug company has agreed to pay more than $35 million to resolve criminal and civil charges that it falsely marketed a cholesterol medication.
www.stltoday.com - RSS Results in business* of type article, St. Louis Post-Dispatch: Business
Fri, 09/22/2017 - 3:42pm
BOSTON (AP) — A Massachusetts drug company has agreed to pay more than $35 million to resolve criminal and civil charges that it falsely marketed a cholesterol medication.